NL7503310A - Verbindingen met antidepressieve werking. - Google Patents

Verbindingen met antidepressieve werking.

Info

Publication number
NL7503310A
NL7503310A NL7503310A NL7503310A NL7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A
Authority
NL
Netherlands
Prior art keywords
connections
antidepressive action
antidepressive
action
Prior art date
Application number
NL7503310A
Other languages
English (en)
Dutch (nl)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Priority to NL7503310A priority Critical patent/NL7503310A/xx
Priority to ZA761434A priority patent/ZA761434B/xx
Priority to DE19762610886 priority patent/DE2610886A1/de
Priority to SE7603341A priority patent/SE410312B/xx
Priority to FI760699A priority patent/FI61875C/fi
Priority to GB10703/76A priority patent/GB1535226A/en
Priority to CA248,102A priority patent/CA1076142A/en
Priority to AT195476A priority patent/AT340895B/de
Priority to PL1976199556A priority patent/PL100052B1/pl
Priority to HU76PI00000513A priority patent/HU171030B/hu
Priority to PL1976188006A priority patent/PL100614B1/pl
Priority to CH334576A priority patent/CH626057A5/de
Priority to GR50333A priority patent/GR60052B/el
Priority to PL1976199557A priority patent/PL101951B1/pl
Priority to IL49238A priority patent/IL49238A/xx
Priority to IT21320/76A priority patent/IT1063064B/it
Priority to DD7600191893A priority patent/DD128332A5/xx
Priority to SU762335241A priority patent/SU635867A3/ru
Priority to DK115976A priority patent/DK144942C/da
Priority to IE567/76A priority patent/IE43768B1/en
Priority to BE165316A priority patent/BE839744A/xx
Priority to YU714/76A priority patent/YU39345B/xx
Priority to AU12147/76A priority patent/AU505358B2/en
Priority to ES446192A priority patent/ES446192A1/es
Priority to JP51029394A priority patent/JPS6026776B2/ja
Priority to US05/668,461 priority patent/US4085225A/en
Priority to FR7608019A priority patent/FR2304336A1/fr
Priority to AR262650A priority patent/AR211011A1/es
Publication of NL7503310A publication Critical patent/NL7503310A/xx
Priority to AR265801A priority patent/AR211153A1/es
Priority to AT41377A priority patent/AT342568B/de
Priority to AT317277A priority patent/AT342574B/de
Priority to SU772503815A priority patent/SU620206A3/ru
Priority to SU772503814A priority patent/SU645559A3/ru
Priority to CH154181A priority patent/CH629761A5/de
Priority to CH153981A priority patent/CH629184A5/de
Priority to CH154081A priority patent/CH629477A5/de
Priority to MX9203723A priority patent/MX9203723A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7503310A 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking. NL7503310A (nl)

Priority Applications (37)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.
ZA761434A ZA761434B (en) 1975-03-20 1976-03-09 Compounds having anti-depressive activity
DE19762610886 DE2610886A1 (de) 1975-03-20 1976-03-16 Verbindungen mit antidepressiver wirkung
SU762335241A SU635867A3 (ru) 1975-03-20 1976-03-17 Способ получени производных оксима или их солей
FI760699A FI61875C (fi) 1975-03-20 1976-03-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara trifluormetylfenon-0-(2-aminoetyl)-oximer
GB10703/76A GB1535226A (en) 1975-03-20 1976-03-17 Oximes
CA248,102A CA1076142A (en) 1975-03-20 1976-03-17 Substituted butyrophenone o-(2-aminoethyl) oxime derivatives
AT195476A AT340895B (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu
HU76PI00000513A HU171030B (hu) 1975-03-20 1976-03-17 Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu
CH334576A CH626057A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-20 1976-03-17
GR50333A GR60052B (en) 1975-03-20 1976-03-17 Preparation process of anti-depressive compounds
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
IL49238A IL49238A (en) 1975-03-20 1976-03-17 O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IT21320/76A IT1063064B (it) 1975-03-20 1976-03-17 Composti aventi attivita antidepressiva a base di eteri ossimici derivati da fenilchetoni
DD7600191893A DD128332A5 (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von verbindungen mit antidepressiver wirkung
SE7603341A SE410312B (sv) 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar
DK115976A DK144942C (da) 1975-03-20 1976-03-17 Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
ES446192A ES446192A1 (es) 1975-03-20 1976-03-18 Un metodo de preparacion de nuevos compuestos de oxima-eter.
IE567/76A IE43768B1 (en) 1975-03-20 1976-03-18 Oximes
BE165316A BE839744A (fr) 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation
YU714/76A YU39345B (en) 1975-03-20 1976-03-18 Process for preparing new oxime ether compounds
AU12147/76A AU505358B2 (en) 1975-03-20 1976-03-18 Alkylphenone-0-(aminoethyl)oxime derivatives
JP51029394A JPS6026776B2 (ja) 1975-03-20 1976-03-19 新規オキシムエーテル化合物
US05/668,461 US4085225A (en) 1975-03-20 1976-03-19 Oxime ethers having anti-depressive activity
FR7608019A FR2304336A1 (fr) 1975-03-20 1976-03-19 Composes a effet anti-depressif et procedes de preparation
AR262650A AR211011A1 (es) 1975-03-20 1976-03-22 Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c3-c4)-sustuitido-ptrifluormetilfenilcetoxin
AR265801A AR211153A1 (es) 1975-03-20 1976-12-10 Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.
AT41377A AT342568B (de) 1975-03-20 1977-01-24 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT317277A AT342574B (de) 1975-03-20 1977-05-04 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
SU772503815A SU620206A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
SU772503814A SU645559A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
CH154181A CH629761A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH153981A CH629184A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154081A CH629477A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
MX9203723A MX9203723A (es) 1975-03-20 1992-06-29 Compuestos que tienen actividad anti-depresiva.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
NL7503310A true NL7503310A (nl) 1976-09-22

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Country Status (27)

Country Link
US (1) US4085225A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6026776B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (2) AR211011A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT340895B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU505358B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE839744A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1076142A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (4) CH626057A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD128332A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2610886A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK144942C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES446192A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI61875C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2304336A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1535226A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR60052B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU171030B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE43768B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL49238A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1063064B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9203723A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7503310A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (3) PL101951B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE410312B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (3) SU635867A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU39345B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA761434B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response
IN182588B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
JP2003530437A (ja) * 2000-04-13 2003-10-14 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ Ａβ４２低下物質
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
AU5565401A (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of depression
CN103288815A (zh) * 2001-10-12 2013-09-11 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
EP1663398B1 (en) 2003-09-12 2009-11-25 Pfizer Limited Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors
JP4864719B2 (ja) * 2003-11-26 2012-02-01 ファイザー・プロダクツ・インク Ｇｓｋ−３インヒビターとしてのアミノピラゾール誘導体
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006102308A2 (en) 2005-03-22 2006-09-28 Azevan Pharmaceuticals, Inc. Beta-lactamyl vasopressin v1b antagonists
AU2006239920A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
WO2006116170A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
MX2007013179A (es) * 2005-04-22 2008-01-16 Wyeth Corp Formas cristalinas de clorhidrato de {[(2r)-7-(diclorofenil)-5- fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina.
CA2605554A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
WO2007008758A2 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
JP5328349B2 (ja) 2005-07-19 2013-10-30 アゼヴァン ファーマスーティカルズ，インコーポレイテッド ベータ−ラクタミルフェニルアラニン、システイン、およびセリン・バソプレッシン拮抗剤
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
PA8720801A1 (es) * 2006-03-24 2008-11-19 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento de la depresion
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
KR101859409B1 (ko) 2009-10-23 2018-05-18 얀센 파마슈티카 엔.브이. 오렉신 수용체 조절제로서의 이치환된 옥타하이드로피롤로［3,4-ｃ］피롤
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
CA2804001C (en) 2010-07-01 2021-02-09 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
KR20140045925A (ko) 2011-03-17 2014-04-17 루핀 리미티드 선택적 세로토닌 재흡수 억제제의 방출조절형 약제학적 조성물
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
WO2014178064A2 (en) * 2013-04-03 2014-11-06 Zcl Chemicals Limited "an improved process for the preparation of fluvoxamine maleate"
CA2938928C (en) 2014-02-07 2023-01-24 Mta Tamogatott Kutatocsoportok Irodaja Use of sigma-1 receptor agonist compounds
KR102725123B1 (ko) 2014-03-28 2024-11-04 아제반 파마슈티칼스, 인코퍼레이티드 신경변성 질환을 치료하기 조성물 및 방법
IL319248A (en) * 2016-03-10 2025-04-01 Janssen Pharmaceutica Nv Methods for treating depression using orexin-2 receptor antagonists
PL3544420T3 (pl) 2016-11-24 2022-11-21 Sigmadrugs Kutató Korlátolt Felelösségü Társaság Zastosowanie kompozycji do konserwowania narządów/tkanek
MX2020002762A (es) 2017-09-15 2020-09-17 Azevan Pharmaceuticals Inc Composiciones y métodos para tratar una lesión cerebral.
CN114375191A (zh) 2019-07-19 2022-04-19 比奥克斯塞尔医疗股份有限公司 非镇静的右美托咪定治疗方案
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Also Published As

Publication number Publication date
US4085225A (en) 1978-04-18
AR211011A1 (es) 1977-10-14
DK115976A (da) 1976-09-21
IE43768B1 (en) 1981-05-20
YU39345B (en) 1984-10-31
JPS6026776B2 (ja) 1985-06-25
SE410312B (sv) 1979-10-08
FR2304336A1 (fr) 1976-10-15
FI61875B (fi) 1982-06-30
FR2304336B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-09-28
SU635867A3 (ru) 1978-11-30
FI61875C (fi) 1982-10-11
DE2610886C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-09-24
SU645559A3 (ru) 1979-01-30
MX9203723A (es) 1992-07-01
ATA195476A (de) 1977-05-15
CH629184A5 (de) 1982-04-15
BE839744A (fr) 1976-09-20
DD128332A5 (de) 1977-11-09
GR60052B (en) 1978-04-04
AU1214776A (en) 1977-09-22
CH629477A5 (de) 1982-04-30
IL49238A0 (en) 1976-05-31
AU505358B2 (en) 1979-11-15
DK144942C (da) 1982-12-06
ZA761434B (en) 1977-10-26
PL101951B1 (pl) 1979-02-28
SU620206A3 (ru) 1978-08-15
PL100052B1 (pl) 1978-08-31
JPS51125345A (en) 1976-11-01
IT1063064B (it) 1985-02-11
CA1076142A (en) 1980-04-22
DK144942B (da) 1982-07-12
PL100614B1 (pl) 1978-10-31
DE2610886A1 (de) 1976-10-07
CH629761A5 (de) 1982-05-14
ES446192A1 (es) 1977-10-01
FI760699A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-09-21
IE43768L (en) 1976-09-20
YU71476A (en) 1982-10-31
AR211153A1 (es) 1977-10-31
IL49238A (en) 1978-08-31
AT340895B (de) 1978-01-10
SE7603341L (sv) 1976-09-21
HU171030B (hu) 1977-10-28
GB1535226A (en) 1978-12-13
CH626057A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-10-30

Similar Documents

Publication Publication Date Title
NL7503310A (nl) Verbindingen met antidepressieve werking.
NO143239C (no) Pumpeanordning.
NO145331C (no) Barberhoevelpatron.
NO144004C (no) Ysteanordning.
NL7611944A (nl) 1,2,3-triazolen met kalmerende werking.
NO141839C (no) Enkeltpunkts-fortoeyningsboeye.
NO803670L (no) Depotsteroidestere.
NL7503312A (nl) Verbindingen met antidepressieve werking.
NL7504370A (nl) Terpenofenoxyalkylaminen met farmacologische werking.
NL7504369A (nl) Terpenofenolen met farmacologische werking.
NL7503309A (nl) Verbindingen met antidepressieve werking.
NL7503311A (nl) Verbindingen met antidepressieve werking.
NO141578C (no) Ionisasjonsroekmelder.
BE849303A (fr) Tranducteur.
NL7610639A (nl) Schouw.
NL7503308A (nl) Verbindingen met antidepressieve werking.
NL7503307A (nl) Antidepressieve verbindingen.
DK135101B (da) Slaglemølle.
NL7610437A (nl) Verbindingen met analgetische werking.
ES209316Y (es) Muneco mecanico.
ES212889Y (es) Cohete-senal.
DK151559C (da) Kartonaeske.
NL7610438A (nl) Nieuwe groep verbindingen met analgetische werking.
NO753264L (no) B{rehank.
ES213937Y (es) Titere simplificado.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: DUPHAR INTERNATIONAL RESEARCH B.V.

BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed